PersonFounderExecutive
Shankar Ramaswamy
Shankar Ramaswamy is the co-founder, chairman and CEO of Kriya Therapeutics, a clinical-stage biopharmaceutical company building one-time gene therapies for common, highly prevalent chronic diseases rather than only rare ones. A physician by training who started his career evaluating drug candidates at Roivant Sciences and helping launch Axovant's record biotech IPO, he founded Kriya in 2019 and has since raised more than $600 million to vertically integrate gene therapy design, computational biology and in-house GMP manufacturing.
gene therapybiotechkriya therapeuticsceoco-founderaav vector